Callisto Capital

Callisto Capital was a Toronto-based private equity firm that specialized in mid-market investments, with a significant strategic focus on the healthcare services sector. Founded in 2002, the firm targeted market-leading companies in Canada and the United States, providing capital for buyouts, recapitalizations, and growth initiatives. Its healthcare portfolio was notable for including major diagnostic and laboratory service providers such as CML Healthcare and LifeLabs, which are central to the Canadian medical infrastructure. While the firm did not engage in direct drug discovery, its investments significantly shaped the delivery of healthcare services in North America. In 2018, the firm's founding partners transitioned to launch Peloton Capital Management, effectively winding down Callisto's new investment activities.